About this trial
The purpose of this research is to compare intermittent fasting with a standard diet approach for improving the quality of life related to your pancreas disease. Our hope is to improve your symptoms and prevent you from needing to go into the hospital for pancreas-related issues.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Age ≥ 18 year
Anatomy of chronic pancreatitis defined by Rosemont criterion9 or on imaging (CT, MRI)
Pancreatic exocrine insufficiency defined by a pancreatic elastase < 200 ug/g stool10
Disqualifiers
Age < 18 years
Pregnant Patients
Age > 80 years
Patients who cannot consent for themselves
Trial design
Parallel
Treatments tested in this trial
Intermittent Fasting
Other interventionThese subjects will will then receive information regarding intermittent fasting, which would include fasting for a 16-hour period each day, followed by ingestion of an appropriate number of calories for the remaining part of the day. See attached IF Quick Facts for details provided to the patient.
No intermittent fasting
Other interventionThese subjects will undergo standard caloric dietary guidance. Patients in group B will also be given the above information, though not be asked to intermittently fast
Treatment groups
Trial outcomes
Primary outcomes
Pancreas related Quality of Life Index (PANQALI)
Pancreas related Quality of Life Index (PANQALI) is pancreas related quality of life index scale from 0 (lowest or better disease activity) to 90 (highest or worse disease activity)
Secondary outcomes
Pain scores
standard score from 0-10 (0 no pain, 10 worst pain)
Oral Morphine Equivalent Daily Dosing
total dose of opiates taken converted into morphine in milligrams
Patient weight
pounds
Patient Body mass index
pounds/inch squared
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: